• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

对来自患乳腺癌和卵巢癌高风险法裔加拿大家庭的乳腺癌病例中HSD17B1序列变异的特征分析。

Characterization of HSD17B1 sequence variants in breast cancer cases from French Canadian families with high risk of breast and ovarian cancer.

作者信息

Plourde Marie, Samson Carolle, Durocher Francine, Sinilnokova Olga, Simard Jacques

机构信息

Cancer Genomics Laboratory, Oncology and Molecular Endocrinology Research Center, Centre Hospitalier Universitaire de Québec and Laval University, Quebec G1V 4G2, Canada.

出版信息

J Steroid Biochem Mol Biol. 2008 Mar;109(1-2):115-28. doi: 10.1016/j.jsbmb.2007.10.004. Epub 2007 Nov 17.

DOI:10.1016/j.jsbmb.2007.10.004
PMID:18083510
Abstract

A family history of disease and estrogen exposure are risk factors for breast cancer. The HSD17B1 gene encodes a key steroidogenic enzyme that catalyses the final step of estradiol biosynthesis, rendering it a good candidate gene for breast cancer susceptibility. The current study was designed to screen for HSD17B1 germline mutations potentially involved in breast cancer susceptibility. DNA samples from 50 individuals affected with breast cancer from non-BRCA1/2 French Canadian families with a high risk of breast and ovarian cancer were screened for sequence variants in HSD17B1. Our study identified 28 sequence variants, including three non-synonymous variants, p.Ala238Val, p.Arg259His, p.Ser313Gly, one of which (p.Arg259His) was not previously reported. Functional assays failed to show changes in either activity or recombinant proteins levels for all three variants. Thus, our resequencing analysis does not support the existence of deleterious, gain-of-function or transcription mutations in HSD17B1, which could explain the clustering of breast cancer cases in non-BRCA1/2 high-risk French Canadian families. However, a haplotype-based approach was used to establish tSNPs, providing a valuable tool for further searches of common disease-associated variants in this gene, using large cohorts.

摘要

疾病家族史和雌激素暴露是乳腺癌的风险因素。HSD17B1基因编码一种关键的类固醇生成酶,催化雌二醇生物合成的最后一步,使其成为乳腺癌易感性的良好候选基因。本研究旨在筛选可能与乳腺癌易感性相关的HSD17B1种系突变。对来自非BRCA1/2法裔加拿大家庭且患乳腺癌和卵巢癌风险较高的50例乳腺癌患者的DNA样本进行HSD17B1序列变异筛查。我们的研究鉴定出28个序列变异,包括三个非同义变异,即p.Ala238Val、p.Arg259His、p.Ser313Gly,其中一个(p.Arg259His)此前未见报道。功能分析未显示这三个变异的活性或重组蛋白水平有变化。因此,我们的重测序分析不支持HSD17B1中存在有害、功能获得或转录突变,而这些突变可能解释非BRCA1/2高风险法裔加拿大家庭中乳腺癌病例的聚集现象。然而,基于单倍型的方法被用于建立标签单核苷酸多态性,为使用大型队列进一步搜索该基因中常见的疾病相关变异提供了一个有价值的工具。

相似文献

1
Characterization of HSD17B1 sequence variants in breast cancer cases from French Canadian families with high risk of breast and ovarian cancer.对来自患乳腺癌和卵巢癌高风险法裔加拿大家庭的乳腺癌病例中HSD17B1序列变异的特征分析。
J Steroid Biochem Mol Biol. 2008 Mar;109(1-2):115-28. doi: 10.1016/j.jsbmb.2007.10.004. Epub 2007 Nov 17.
2
Mutation analysis and characterization of ATR sequence variants in breast cancer cases from high-risk French Canadian breast/ovarian cancer families.来自高危法裔加拿大乳腺癌/卵巢癌家族的乳腺癌病例中ATR序列变异的突变分析与特征描述
BMC Cancer. 2006 Sep 29;6:230. doi: 10.1186/1471-2407-6-230.
3
Mutation analysis and characterization of HSD17B2 sequence variants in breast cancer cases from French Canadian families with high risk of breast and ovarian cancer.对来自患乳腺癌和卵巢癌高风险法裔加拿大家庭的乳腺癌病例中HSD17B2序列变异的突变分析与特征描述。
J Mol Endocrinol. 2008 Apr;40(4):161-72. doi: 10.1677/JME-07-0101.
4
Analysis of 17beta-hydroxysteroid dehydrogenase types 5, 7, and 12 genetic sequence variants in breast cancer cases from French Canadian Families with high risk of breast and ovarian cancer.对来自患乳腺癌和卵巢癌高风险法裔加拿大家庭的乳腺癌病例中17β-羟类固醇脱氢酶5型、7型和12型基因序列变异的分析。
J Steroid Biochem Mol Biol. 2009 Sep;116(3-5):134-53. doi: 10.1016/j.jsbmb.2009.05.005. Epub 2009 May 19.
5
[The limited spectrum of pathogenic BRCA1 and BRCA2 mutations in the French Canadian breast and breast-ovarian cancer families, a founder population of Quebec, Canada].[加拿大魁北克奠基人群体法裔加拿大乳腺癌和乳腺-卵巢癌家族中致病性BRCA1和BRCA2突变的有限谱]
Bull Cancer. 2006 Sep;93(9):841-6.
6
Haplotype analysis of the HSD17B1 gene and risk of breast cancer: a comprehensive approach to multicenter analyses of prospective cohort studies.HSD17B1基因单倍型分析与乳腺癌风险:前瞻性队列研究多中心分析的综合方法
Cancer Res. 2006 Feb 15;66(4):2468-75. doi: 10.1158/0008-5472.CAN-05-3574.
7
Analysis of ZNF350/ZBRK1 promoter variants and breast cancer susceptibility in non-BRCA1/2 French Canadian breast cancer families.分析 ZNF350/ZBRK1 启动子变异与非 BRCA1/2 法裔加拿大乳腺癌家族的乳腺癌易感性。
J Hum Genet. 2013 Feb;58(2):59-66. doi: 10.1038/jhg.2012.127. Epub 2012 Nov 15.
8
Haplotype analysis suggest common founders in carriers of the recurrent BRCA2 mutation, 3398delAAAAG, in French Canadian hereditary breast and/ovarian cancer families.单倍型分析表明,在法裔加拿大遗传性乳腺癌和/卵巢癌家族中,复发性BRCA2突变(3398delAAAAG)携带者存在共同的始祖。
BMC Med Genet. 2006 Mar 15;7:23. doi: 10.1186/1471-2350-7-23.
9
Genetic sequence variations of BRCA1-interacting genes AURKA, BAP1, BARD1 and DHX9 in French Canadian families with high risk of breast cancer.BRCA1 相互作用基因 AURKA、BAP1、BARD1 和 DHX9 的遗传序列变异在具有乳腺癌高风险的法裔加拿大家族中。
J Hum Genet. 2009 Mar;54(3):152-61. doi: 10.1038/jhg.2009.6. Epub 2009 Feb 6.
10
Genetic variants and haplotype analyses of the ZBRK1/ZNF350 gene in high-risk non BRCA1/2 French Canadian breast and ovarian cancer families.高危非BRCA1/2法裔加拿大乳腺癌和卵巢癌家族中ZBRK1/ZNF350基因的遗传变异和单倍型分析
Int J Cancer. 2008 Jan 1;122(1):108-16. doi: 10.1002/ijc.23058.

引用本文的文献

1
Variants of 11β-hydroxysteroid dehydrogenase (HSD11B) gene type 1 and 2 in Chinese obese adolescents.中国肥胖青少年中11β-羟基类固醇脱氢酶(HSD11B)1型和2型基因的变体
J Endocrinol Invest. 2014 Jun;37(6):565-73. doi: 10.1007/s40618-014-0075-8. Epub 2014 Apr 11.